Research Paper Volume 16, Issue 1 pp 285—298
MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer
Figure 2. Prognostic role of MAGE-A family members. (A) Survival curve from the website Kaplan-Meier plotter. (B) Survival curves constructed by TCGA clinical and expression data.